Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a case control study

Laparoscopic stripping of recurrent ovarian endometriomas decreases antimullerian hormone levels, increases basal FSH, and decreases the antral follicle count and volume of the operated ovary.

Like Comment


Simone Ferrero, Ph.D., Carolina Scala, M.D., Annalisa Racca, M.D., Luana Calanni, M.D., Valentino Remorgida, M.D., Pier Luigi Venturini, M.D., Umberto Leone Roberti Maggiore, M.D.

Volume 103, Issue 5, Pages 1236-1243



To investigate the impact on ovarian reserve of second laparoscopic surgery for recurrent unilateral endometriomas.


Case-control study.


University teaching hospital.


This study included patients who underwent stripping of endometriomas (diameter ≥4 cm) and were followed-up at our institution. Case subjects had second surgery for recurrent unilateral endometriomas (n = 18); control subjects had no recurrence and no second surgery (n = 18).


This case-control study was based on a retrospective analysis of a prospectively collected database including patients who underwent surgery for endometriomas at our institution.

Main Outcome Measure(s):

The primary outcome of the study was to assess the changes in antimüllerian hormone (AMH) levels in each study group and between the two study groups. The secondary outcomes of the study were to assess the changes in basal FSH, antral follicle count (AFC), and ovarian volume in each study group and between the two study groups.


In both study groups, primary surgery decreased AMH, increased basal FSH, and decreased the AFC of the operated ovary. Before second surgery, case subjects had AMH, basal FSH, and AFC similar to control subjects. After second surgery, case subjects had lower AMH, higher basal FSH, and lower AFC of the affected ovary than before surgery; the volume of the operated ovary was lower than that of the contralateral ovary.


The laparoscopic stripping of recurrent ovarian endometriomas is associated with a high risk of ovarian reserve damage and ovarian failure.

Clinical Trial Registration Number:


Read the full text at:

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.